Mehmet Hocaoglu to Humans
This is a "connection" page, showing publications Mehmet Hocaoglu has written about Humans.
Connection Strength
0.248
-
Hocaoglu M, Sawalha AH. Integrated analysis of polygenic and environmental risk scores for late-onset systemic lupus erythematosus. J Autoimmun. 2025 Jun; 154:103441.
Score: 0.034
-
Hocaoglu M, Jaros B, Dua AB, Sattui SE. Epidemiology of systemic vasculitis. Curr Opin Rheumatol. 2025 Mar 01; 37(2):113-120.
Score: 0.033
-
Hocaoglu M, Casares-Marfil D, Sawalha AH. Genetic Analysis of Asymptomatic Antinuclear Antibody Production. Arthritis Rheumatol. 2025 Mar; 77(3):356-361.
Score: 0.033
-
Hocaoglu M, Valenzuela-Almada MO, Dabit JY, Osei-Onomah SA, Chevet B, Giblon RE, Zand L, Fervenza FC, Helmick CG, Crowson CS, Duarte-Garc?a A. Incidence, Prevalence, and Mortality of Lupus Nephritis: A Population-Based Study Over Four Decades Using the Lupus Midwest Network. Arthritis Rheumatol. 2023 04; 75(4):567-573.
Score: 0.029
-
Hocaoglu M, Davis MDP, Osei-Onomah SA, Valenzuela-Almada MO, Dabit JY, Duong SQ, Yang JX, Helmick CG, Crowson C, Duarte-Garc?a A. Epidemiology of Cutaneous Lupus Erythematosus Among Adults Over Four Decades (1976-2018): A Lupus Midwest Network (LUMEN) Study. Mayo Clin Proc. 2022 12; 97(12):2282-2290.
Score: 0.029
-
Hocaoglu M, Durmus H, ?zkan B, Yent?r SP, Dogan ?, Parman Y, Deymeer F, Saruhan-Direskeneli G. Increased costimulatory molecule expression of thymic and peripheral B cells and a sensitivity to IL-21 in myasthenia gravis. J Neuroimmunol. 2018 10 15; 323:36-42.
Score: 0.021
-
Figueroa-Parra G, Meade-Aguilar JA, Langenfeld HE, Gonz?lez-Trevi?o M, Hocaoglu M, Hanson AC, Prokop LJ, Murad MH, Cartin-Ceba R, Specks U, Majithia V, Crowson CS, Duarte-Garc?a A. Clinical features, risk factors, and outcomes of diffuse alveolar hemorrhage in antiphospholipid syndrome: A mixed-method approach combining a multicenter cohort with a systematic literature review. Clin Immunol. 2023 11; 256:109775.
Score: 0.008
-
Figueroa-Parra G, Jeffery MM, Dabit JY, Chevet B, Valenzuela-Almada MO, Hocaoglu M, Osei-Onomah SA, Kurani S, Vallejo S, Achenbach SJ, Hooten WM, Barbour KE, Crowson CS, Duarte-Garc?a A. Long-Term Opioid Therapy Among Patients With Systemic Lupus Erythematosus in the Community: A Lupus Midwest Network (LUMEN) Study. J Rheumatol. 2023 04; 50(4):504-511.
Score: 0.007
-
Chevet B, Figueroa-Parra G, Valenzuela-Almada MO, Hocaoglu M, Vallejo S, Osei-Onomah SA, Giblon RE, Dabit JY, Chamberlain AM, Cornec D, Greenlund KJ, Barbour KE, Crowson CS, Duarte-Garc?a A. Health Care Utilization in Systemic Lupus Erythematosus in the Community: The Lupus Midwest Network. J Clin Rheumatol. 2023 Jan 01; 29(1):29-35.
Score: 0.007
-
Chevet B, Figueroa-Parra G, Yang JX, Hocaoglu M, Osei-Onomah SA, Hulshizer CA, Gunderson TM, Cornec D, Barbour KE, Greenlund KJ, Crowson CS, Duarte-Garc?a A. Utilization of preventive services in a systemic lupus erythematosus population-based cohort: a Lupus Midwest Network (LUMEN) study. Arthritis Res Ther. 2022 09 01; 24(1):211.
Score: 0.007
-
Dabit JY, Hocaoglu M, Moder KG, Barkmeier AJ, Smith WM, O'Byrne TJ, Crowson CS, Duarte-Garc?a A. Risk of hydroxychloroquine retinopathy in the community. Rheumatology (Oxford). 2022 08 03; 61(8):3172-3179.
Score: 0.007
-
Duarte-Garc?a A, Hocaoglu M, Osei-Onomah SA, Dabit JY, Giblon RE, Helmick CG, Crowson CS. Population-based incidence and time to classification of systemic lupus erythematosus by three different classification criteria: a Lupus Midwest Network (LUMEN) study. Rheumatology (Oxford). 2022 05 30; 61(6):2424-2431.
Score: 0.007
-
Valenzuela-Almada MO, Hocaoglu M, Dabit JY, Osei-Onomah SA, Basiaga ML, Orandi AB, Giblon RE, Barbour KE, Crowson CS, Duarte-Garc?a A. Epidemiology of Childhood-Onset Systemic Lupus Erythematosus: A Population-Based Study. Arthritis Care Res (Hoboken). 2022 05; 74(5):728-732.
Score: 0.007
-
Rajasimhan S, Schiffenbauer A, Hocaoglu M, Fike A, Katz JD. Report of a Homeopathic Medication Regimen Containing Artemether/Lumefantrine in a Patient With Rheumatoid Arthritis. J Clin Rheumatol. 2021 Dec 01; 27(8S):S447-S448.
Score: 0.007
-
Duarte-Garc?a A, Myasoedova E, Karmacharya P, Hocaoglu M, Murad MH, Warrington KJ, Crowson CS. Effect of omega-3 fatty acids on systemic lupus erythematosus disease activity: A systematic review and meta-analysis. Autoimmun Rev. 2020 Dec; 19(12):102688.
Score: 0.006
-
?ebi M, Durmus H, Aysal F, ?zkan B, G?l GE, ?akar A, Hocaoglu M, Mercan M, Yent?r SP, T?t?nc? M, Yayla V, Akan O, Dogan ?, Parman Y, Saruhan-Direskeneli G. CD4+ T Cells of Myasthenia Gravis Patients Are Characterized by Increased IL-21, IL-4, and IL-17A Productions and Higher Presence of PD-1 and ICOS. Front Immunol. 2020; 11:809.
Score: 0.006